Veno-venous extracorporeal membrane oxygenation bridged living-donor lung transplantation for rapid progressive respiratory failure with pleuroparenchymal fibroelastosis after allogeneic hematopoietic stem cell transplantation

Respir Investig. 2018 May;56(3):258-262. doi: 10.1016/j.resinv.2017.12.009. Epub 2018 Feb 12.

Abstract

Cases of extracorporeal membrane oxygenation (ECMO) bridged lung transplantation (LTx) are rare in Japan because an allocation system to prioritize patients based on urgency remains to be established. For critically ill patients who cannot wait for a brain-dead donor LTx, ECMO bridge to living-donor LTx may be the only practical option. A 21-year-old woman with pleuroparenchymal fibroelastosis after hematopoietic stem cell transplantation was admitted to our hospital with rapidly progressive respiratory failure. She was waitlisted for 6 months before admission, but veno-venous ECMO was initiated. She was transported under ECMO support via a jet plane and underwent successful living-donor LTx.

Keywords: ECMO; Lung allocation; Lung transplantation; Pleuroparenchymal fibroelastosis.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Allografts*
  • Disease Progression
  • Extracorporeal Membrane Oxygenation / methods*
  • Female
  • Hematopoietic Stem Cell Transplantation* / adverse effects
  • Humans
  • Living Donors*
  • Lung Diseases, Interstitial / etiology*
  • Lung Transplantation / methods*
  • Lymphoma, B-Cell / therapy
  • Postoperative Complications / etiology*
  • Respiratory Insufficiency / etiology*
  • Respiratory Insufficiency / therapy*
  • Treatment Outcome
  • Young Adult